U.S. flag

An official website of the United States government

NM_024685.4(BBS10):c.1956C>G (p.Tyr652Ter) AND Bardet-Biedl syndrome

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Aug 17, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003331595.1

Allele description [Variation Report for NM_024685.4(BBS10):c.1956C>G (p.Tyr652Ter)]

NM_024685.4(BBS10):c.1956C>G (p.Tyr652Ter)

Gene:
BBS10:Bardet-Biedl syndrome 10 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
12q21.2
Genomic location:
Preferred name:
NM_024685.4(BBS10):c.1956C>G (p.Tyr652Ter)
HGVS:
  • NC_000012.12:g.76346029G>C
  • NG_016357.1:g.7414C>G
  • NM_024685.4:c.1956C>GMANE SELECT
  • NP_078961.3:p.Tyr652Ter
  • LRG_1255t1:c.1956C>G
  • LRG_1255:g.7414C>G
  • LRG_1255p1:p.Tyr652Ter
  • NC_000012.11:g.76739809G>C
  • NM_024685.3:c.1956C>G
Protein change:
Y652*
Molecular consequence:
  • NM_024685.4:c.1956C>G - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Bardet-Biedl syndrome (BBS)
Identifiers:
MONDO: MONDO:0015229; MedGen: C0752166; Orphanet: 110; OMIM: PS209900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004037966Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Pathogenic
(Aug 17, 2023)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV004037966.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Variant summary: BBS10 c.1956C>G (p.Tyr652X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein. While it is not expected to undergo nonsense-mediated decay, it eliminates the last 71 amino acids from the encoded protein. Variants downstream of this position have been classified as pathogenic by our laboratory (p.Val707X, CV ID 406221) and in ClinVar (c.2044dup/p.Met682fs CV ID 1454610, c.2052del/ p.Lys684fs CV ID 952132). This suggests that this is a clinically significant region of the protein. The variant was absent in 251128 control chromosomes (gnomAD). To our knowledge, no occurrence of c.1956C>G in individuals affected with Bardet-Biedl Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. No submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 7, 2023